science
plus
.abes.fr
|
explorer
À propos de :
Pineda Juan A.
Goto
Sponge
NotDistinct
Permalink
An Entity of Type :
foaf:Person
, within Data Space :
scienceplus.abes.fr
associated with source
document(s)
Type:
Person
New Facet based on Instances of this Class
Attributs
Valeurs
type
Person
name
Pineda Juan A.
Pineda Juan Antonio
Pineda J. A.
Pineda Juan A.
personal mailbox
japineda@nacom.es
japineda@telefonica.net
familyName
Pineda
Given name
J. A.
J A
Juan Antonio
Juan A.
Juan A.
is
relates
of
http://hub.abes.fr/bmj/periodical/gut/2009/volume_58/issue_12/B356DBB03462045AE053120B220A35DA/authorship/15
http://hub.abes.fr/oup/periodical/cid/2009/volume_48/issue_10/101086598333/authorship/8
http://hub.abes.fr/oup/periodical/cid/2010/volume_51/issue_7/101086656235/authorship/1
http://hub.abes.fr/bmj/periodical/gutjnl/2006/volume_55/issue_3/B356DBB02EEE045AE053120B220A35DA/authorship/12
http://hub.abes.fr/oup/periodical/jac/2009/volume_63/issue_1/101093jacdkn429/authorship/12
http://hub.abes.fr/oup/periodical/cid/2007/volume_45/issue_8/101086521857/authorship/14
http://hub.abes.fr/oup/periodical/cid/2010/volume_51/issue_10/101086656811/authorship/15
http://hub.abes.fr/oup/periodical/cid/2009/volume_49/issue_8/101086605677/authorship/15
http://hub.abes.fr/oup/periodical/jac/2008/volume_62/issue_4/101093jacdkn262/authorship/3
http://hub.abes.fr/oup/periodical/jac/2007/volume_59/issue_3/101093jacdkl524/authorship/3
http://hub.abes.fr/oup/periodical/jac/2007/volume_60/issue_6/101093jacdkm373/authorship/1
http://hub.abes.fr/oup/periodical/jac/2008/volume_62/issue_6/101093jacdkn420/authorship/19
http://hub.abes.fr/oup/periodical/cid/2001/volume_32/issue_4/101086318708/authorship/2
http://hub.abes.fr/oup/periodical/jac/2010/volume_65/issue_10/101093jacdkq272/authorship/12
http://hub.abes.fr/oup/periodical/jid/1994/volume_169/issue_2/101093infdis1692267/authorship/3
http://hub.abes.fr/oup/periodical/jac/2005/volume_55/issue_4/101093jacdkh555/authorship/1
http://hub.abes.fr/oup/periodical/jac/2006/volume_58/issue_1/101093jacdkl214/authorship/13
http://hub.abes.fr/oup/periodical/trstmh/1996/volume_90/issue_4/101016s0035920396905143/authorship/2
http://hub.abes.fr/oup/periodical/jid/2005/volume_192/issue_9/101086491736/authorship/11
http://hub.abes.fr/oup/periodical/jac/2006/volume_57/issue_5/101093jacdkl074/authorship/1
http://hub.abes.fr/oup/periodical/trstmh/2001/volume_95/issue_2/101016s0035920301901518/authorship/1
http://hub.abes.fr/oup/periodical/jac/2007/volume_59/issue_1/101093jacdkl447/authorship/10
http://hub.abes.fr/oup/periodical/cid/2009/volume_49/issue_8/101086605676/authorship/1
http://hub.abes.fr/oup/periodical/cid/1998/volume_26/issue_1/101086517029/authorship/9
http://hub.abes.fr/oup/periodical/jid/2008/volume_197/issue_3/101086525043/authorship/7
http://hub.abes.fr/oup/periodical/jac/2008/volume_61/issue_4/101093jacdkn045/authorship/1
http://hub.abes.fr/springer/periodical/10096/1993/volume_12/issue_11/B901D968E3523B97E053120B220AAC03/authorship/7
http://hub.abes.fr/springer/periodical/10096/1995/volume_14/issue_5/B90196BD57053A0BE053120B220A4E5C/authorship/1
http://hub.abes.fr/springer/periodical/10096/1989/volume_8/issue_3/B901D968E4CA3B97E053120B220AAC03/authorship/2
http://hub.abes.fr/springer/periodical/10096/1991/volume_10/issue_9/B901D968E9543B97E053120B220AAC03/authorship/4
http://hub.abes.fr/springer/periodical/10096/1994/volume_13/issue_5/B901D968E5653B97E053120B220AAC03/authorship/6
http://hub.abes.fr/springer/periodical/10096/1990/volume_9/issue_8/B901D968E1FB3B97E053120B220AAC03/authorship/4
http://hub.abes.fr/springer/periodical/10096/1993/volume_12/issue_9/B901D968E34D3B97E053120B220AAC03/authorship/3
is
Author
of
Isolated renal mucormycosis in two AIDS patients
Increased Hepatocyte Fas Expression and Apoptosis in HIV and Hepatitis C Virus Coinfection
Decrease in Serial Prevalence of Coinfection with Hepatitis C Virus among HIV-Infected Patients in Spain, 1997-2006
Hepatic safety of tipranavir plus ritonavir (TPV/r)-based antiretroviral combinations: effect of hepatitis virus co-infection and pre-existing fibrosis
Provirus Load Changes in Untreated and Zidovudine-Treated Human Immunodeficiency Virus Type I-Infected Patients
Liver toxicity induced by non-nucleoside reverse transcriptase inhibitors
Influence of concomitant antiretroviral therapy on the rate of sustained virological response to pegylated interferon plus ribavirin in hepatitis C virus/HIV-coinfected patients
Progression of liver fibrosis in patients coinfected with hepatitis C virus and human immunodeficiency virus undergoing antiretroviral therapy
Regression of Invasive AIDS-Related Kaposi's Sarcoma Following Antiretroviral Therapy
Incidence of and risk factors for severe hepatotoxicity of nelfinavir-containing regimens among HIV-infected patients with chronic hepatitis C
Liver toxicity of antiretroviral combinations including atazanavir/ritonavir in patients co-infected with HIV and hepatitis viruses: impact of pre-existing liver fibrosis
Efficacy of pegylated interferon plus ribavirin treatment in HIV/hepatitis C virus co-infected patients receiving abacavir plus lamivudine or tenofovir plus either lamivudine or emtricitabine as nucleoside analogue backbone
Efficacy of pegylated interferon and ribavirin for retreatment of chronic HCV infection in HIV co-infected patients failing a previous standard interferon-based regimen
False-positive results of leishmanin skin test due to phenol-containing diluent
Vitamin D Receptor Gene Haplotypes and Susceptibility to HIV-1 Infection in Injection Drug Users
Influence of Highly Active Antiretroviral Therapy on the Outcome of Subclinical Visceral Leishmaniasis in Human Immunodeficiency Virus-Infected Patients
The Use of Transient Elastometry for Assessing Liver Fibrosis in Patients with HIV and Hepatitis C Virus Coinfection
Efficacy and Safety of Pegylated Interferon plus Ribavirin in HIV and Hepatitis C Virus-Coinfected Patients with Advanced Immunosuppression
Low incidence of severe liver toxicity in patients receiving antiretroviral combinations including atazanavir
Changes in liver stiffness in patients with chronic hepatitis C with and without HIV co-infection treated with pegylated interferon plus ribavirin
Natural History of Compensated Hepatitis C Virus-Related Cirrhosis in HIV-Infected Patients
Low-level liver enzyme elevations during HAART are not associated with liver fibrosis progression among HIV/HCV-coinfected patients
Prediction of Response to Pegylated Interferon plus Ribavirin by IL28B Gene Variation in Patients Coinfected with HIV and Hepatitis C Virus
Modeling the Probability of Sustained Virological Response to Therapy with Pegylated Interferon plus Ribavirin in Patients Coinfected with Hepatitis C Virus and HIV
Specificity of a commercial indirect immunofluorescence technique in the diagnosis of visceral leishmaniasis in patients infected with HIV-1
Hepatitis C virus infection in sexually promiscuous groups
Hepatitis C virus infection among sexually promiscuous groups and the heterosexual partners of hepatitis C virus infected index cases
Failure to detect silent HIV infection by polymerase chain reaction in subjects at risk for heterosexually transmitted HIV type 1 infection
Absence of HTLV-I and HTLV-II infection in prostitutes in the area of seville, Spain
Predictive value of the presence of P24 antigen in persons with antibodies to human immunodeficiency virus in Spain
Association between hepatitis C virus seroreactivity and HIV infection in non-intravenous drug abusing prostitutes
Alternative Linked Data Documents:
ODE
Content Formats:
RDF
ODATA
Microdata
